Todd W Miller Selected Research

exemestane (Aromasin)

2/2018	Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer.
9/2016	Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Todd W Miller Research Topics

Disease

53	Neoplasms (Cancer) 04/2024 - 09/2005
45	Breast Neoplasms (Breast Cancer) 02/2024 - 05/2009
6	Triple Negative Breast Neoplasms 04/2024 - 01/2019
4	Disease Progression 08/2020 - 05/2003
4	Huntington Disease (Huntington's Disease) 09/2005 - 05/2003
3	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2005 - 05/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Non-Muscle Invasive Bladder Neoplasms 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 09/2019
1	Ductal Carcinoma 01/2019
1	Adenocarcinoma 01/2019
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

24	Estrogen ReceptorsIBA 01/2023 - 05/2009
21	Estrogens (Estrogen)FDA Link 02/2024 - 07/2010
16	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2023 - 05/2009
13	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2003
10	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018 - 01/2011
9	Aromatase InhibitorsIBA 01/2023 - 04/2011
9	Hormones (Hormone)IBA 01/2019 - 05/2009
8	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 05/2003
7	Estrogen Receptor alphaIBA 02/2024 - 01/2014
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2003
7	Phosphotransferases (Kinase)IBA 01/2018 - 05/2009
6	Fulvestrant (Faslodex)FDA Link 01/2019 - 05/2009
3	eribulin FDA Link 02/2024 - 04/2023
3	Letrozole (Femara)FDA LinkGeneric 02/2018 - 04/2011
3	Mechanistic Target of Rapamycin Complex 1IBA 02/2018 - 03/2017
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2014 - 05/2009
3	Tamoxifen FDA LinkGeneric 11/2011 - 05/2009
3	Tyrosine Kinase InhibitorsIBA 11/2011 - 05/2009
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2023 - 01/2023
2	AlpelisibIBA 01/2023 - 06/2017
2	Everolimus FDA Link 01/2023 - 02/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2020
2	Dietary Fats (Dietary Fat)IBA 01/2020 - 01/2020
2	LipidsIBA 01/2020 - 01/2014
2	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 02/2018 - 11/2011
2	exemestane (Aromasin)FDA Link 02/2018 - 09/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 05/2009
2	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2018 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2017 - 10/2013
2	LigandsIBA 11/2016 - 01/2012
2	TensinsIBA 01/2014 - 05/2009
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2014 - 01/2014
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013 - 11/2011
2	Small Interfering RNA (siRNA)IBA 10/2012 - 05/2009
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 11/2011 - 05/2009
2	Annexin A5IBA 12/2009 - 07/2009
2	Trastuzumab (Herceptin)FDA Link 12/2009 - 07/2009
2	Single-Chain AntibodiesIBA 08/2005 - 06/2005
2	polyglutamineIBA 08/2005 - 06/2005
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2024
1	Ligases (Synthetase)IBA 02/2024
1	Biotin (Vitamin H)FDA Link 02/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2024
1	MethyltransferasesIBA 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Gemcitabine FDA Link 01/2021
1	B7-H1 AntigenIBA 11/2020
1	130-nm albumin-bound paclitaxelIBA 11/2020
1	Circulating Tumor DNAIBA 08/2020
1	VLDL LipoproteinsIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	ribociclibIBA 09/2019
1	Retinoblastoma ProteinIBA 09/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2019
1	CytokinesIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	palbociclibIBA 01/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018
1	Chloroquine (Aralen)FDA LinkGeneric 01/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2018
1	Therapeutic UsesIBA 06/2017
1	Cytotoxins (Cytolysins)IBA 06/2017
1	GSK2636771IBA 06/2017
1	Cytostatic AgentsIBA 06/2017
1	Growth Factor ReceptorsIBA 06/2017
1	Protein Isoforms (Isoforms)IBA 06/2017
1	PF-4708671IBA 03/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 03/2017
1	EHT 1864IBA 03/2017
1	GTP Phosphohydrolases (GTPases)IBA 03/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2016

Therapy/Procedure

35	Therapeutics 04/2024 - 09/2005
7	Drug Therapy (Chemotherapy) 04/2024 - 07/2012
3	Neoadjuvant Therapy 11/2020 - 04/2011
2	Immunotherapy 11/2020 - 08/2020
1	Precision Medicine 01/2019
1	Radiotherapy 01/2019